If youre considering GLP-1 treatment as part of your weight or metabolic health strategy with hypothyroidism or Hashimotos, being a Paloma Health member can provide you with the essential support you need
The CMAJ guidance A guidance article published in the Canadian Medical Association Journal (CMAJ) on glucagon-like peptide-1 receptor agonists during pregnancy and lactation concluded that while the safety data is limited, the pharmacological properties of GLP-1 agonists (large molecular weight, poor oral bioavailability) suggest low theoretical risk during breastfeeding
For another science-forward perspective, see Does Liposomal Glutathione Work
Pala L, De Pas T, Catania C, Giaccone G, Mantovani A, Minucci S, et al
Starting at $99 per month